Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service

被引:26
作者
Paterniti, Sabrina [1 ,2 ]
Bisserbe, Jean-Claude [1 ]
机构
[1] Univ Ottawa, Dept Psychiat, Ottawa, ON K1N 6N5, Canada
[2] Royal Ottawa Mental Hlth Ctr, Ottawa, ON K1Z 7K4, Canada
关键词
Bipolar disorder; Pharmacotherapy; Treatment; Guidelines; PSYCHIATRY WFSBP GUIDELINES; ANXIETY TREATMENTS CANMAT; MAJOR DEPRESSIVE EPISODE; PSYCHOTROPIC-DRUG PRESCRIPTION; QUALITY-OF-CARE; ANTIDEPRESSANT TREATMENT; BIOLOGICAL TREATMENT; WORLD-FEDERATION; I DISORDER; PHARMACOLOGICAL-TREATMENT;
D O I
10.1186/1471-244X-13-211
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Many new approaches have been adopted for the treatment of bipolar disorder (BD) in the past few years, which strived to produce more positive outcomes. To enhance the quality of care, several guideline recommendations have been developed. For study purposes, we monitored the prescription of psychotropic drugs administered to bipolar patients who had been referred to tertiary care services, and assessed the degree to which treatment met specific guidelines. Methods: Between December 2006 and February 2009, we assessed 113 individuals suffering from BD who had been referred to the Royal Ottawa Mental Health Centre (ROMHC) Mood Disorders Program by physicians within the community, mostly general practitioners. The Structured Clinical Interview for DSM-IV-TR was used to assess diagnosis. The prescribed treatment was compared with specific Canadian guidelines (CANMAT, 2009). Univariate analyses and logistic regression were used to assess the contribution of demographic and clinical factors for concordance of treatment with guidelines. Results: Thirty-two subjects had BD type I (BD-I), and 81 subjects had BD type II (BD-II). All subjects with BD-I, and 90% of the BD-II group were given at least one psychotropic treatment. Lithium was more often prescribed for subjects with BD-I (62%) than those with BD-II (19%). Antidepressants were the most frequently prescribed class of psychotropics. Sixty-eight percent of subjects received treatment concordant with guidelines by medication and dose. The presence of a current hypomanic episode was independently associated with poorer concordance to guidelines. In more than half the cases, the inappropriate use of antidepressants was at the origin of the non concordance of treatment with respect to guidelines. Absence of psychotropic treatment in bipolar II patients and inadequate dosage of mood stabilizers were the two other main causes of non concordance with guidelines. Conclusions: The factors related to treatment not concordant with guidelines should be further explored to determine appropriate strategies in implementing the use of guidelines in clinical practice.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 87 条
  • [1] Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression
    Agosti, Vito
    Stewart, Jonathan W.
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (05) : 309 - 311
  • [2] Treatment of bipolar affective disorder in clinical practice
    Ahmed, Z
    Anderson, IM
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2001, 15 (01) : 55 - 57
  • [3] Altmbas K, 2011, PSYCHIAT DANUB, V23, P189
  • [4] Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up
    Altshuler, L
    Suppes, T
    Black, D
    Nolen, WA
    Keck, PE
    Frye, MA
    McElroy, S
    Kupka, R
    Grunze, H
    Walden, J
    Leverich, G
    Denicoff, K
    Luckenbaugh, D
    Post, R
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (07) : 1252 - 1262
  • [5] Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants
    Altshuler, LL
    Suppes, T
    Black, DO
    Nolen, WA
    Leverich, G
    Keck, PE
    Frye, MA
    Kupka, R
    McElroy, SL
    Grunze, H
    Kitchen, CMR
    Post, R
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (02) : 313 - 315
  • [6] Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study
    Altshuler, Lori L.
    Post, Robert M.
    Hellemann, Gerhard
    Leverich, Gabriele S.
    Nolen, Willem A.
    Frye, Mark A.
    Keck, Paul E., Jr.
    Kupka, Ralph W.
    Grunze, Heinz
    McElroy, Susan L.
    Sugar, Catherine A.
    Suppes, Trisha
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (04) : 450 - 457
  • [7] Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode - A randomized open-label study
    Amsterdam, Jay D.
    Shults, Justine
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (02) : 171 - 181
  • [8] Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: A randomized, parallel group, open-label trial
    Amsterdam, Jay D.
    Wang, Chia-Hao
    Shwarz, Michelle
    Shults, Justine
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2009, 112 (1-3) : 219 - 230
  • [9] Changes in pharmacological treatment for bipolar disorder over time in Manchester:: a comparison with Lloyd et al. (2003)
    Anderson, IM
    Haddad, PM
    Chaudhry, I
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (03) : 441 - 443
  • [10] Prevalence and Characteristics of Undiagnosed Bipolar Disorders in Patients With a Major Depressive Episode The BRIDGE Study
    Angst, Jules
    Azorin, Jean-Michel
    Bowden, Charles L.
    Perugi, Giulio
    Vieta, Eduard
    Gamma, Alex
    Young, Allan H.
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2011, 68 (08) : 791 - 799